Heat Biologics, Inc.
HTBX
Price:
$2.38
Market Cap:
$61.07M
Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety of illnesses, including both cancerous growths and infectious diseases. A cornerstone of their approach is the gp96 platform, which comprises two key components: ImPACT, an allogenic cell-based system designed to stimulate and proliferate T-cells as an immune activator, and ComPACT, a singular product engineered to achieve both antigen-driven T-cell activation and specific co-stimulation simultaneously. Their development pipeline includes several clinical-stage assets. HS-110 has finished enrol...[Read more]
Industry
Biotechnology
IPO Date
2013-07-24
Stock Exchange
AMEX
Ticker
HTBX
PE Ratio
[-2.07]
ROE
[28.83%]
Current Ratio
[0.00]
Dividend Yield
[0%]
Enterprise Value
[18.12T]
Dividend History
The ROE as of June 2026 (TTM) for Heat Biologics, Inc. (HTBX) is 28.83%
According to Heat Biologics, Inc.’s latest financial reports and current stock price. The company's current ROE is 28.83%. This represents a change of -321.42% compared to the average of -13019751.07% of the last 4 quarters.
Heat Biologics, Inc. (HTBX) Historical ROE (quarterly & annually)
How has HTBX ROE performed in the past?
The mean historical ROE of Heat Biologics, Inc. over the last ten years is -102.97%. The current 28.83% ROE has changed -27997368.86% with respect to the historical average. Over the past ten years (40 quarters), HTBX's ROE was at its highest in in the June 2025 quarter at 16.42%. The ROE was at its lowest in in the December 2024 quarter at -52079035.95%.
Average
-102.97%
Median
-76.09%
Minimum
-500.99%
Maximum
168.20%
Heat Biologics, Inc. (HTBX) ROE by Quarter and Year
Discovering the peaks and valleys of Heat Biologics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 399.78%
Maximum Annual ROE = 168.20%
Minimum Annual Increase = -123.55%
Minimum Annual ROE = -500.99%
| Year | ROE | Change |
|---|---|---|
| 2021 | -31.60% | 41.00% |
| 2020 | -22.41% | -84.81% |
| 2019 | -147.50% | 183.95% |
| 2018 | -51.94% | -67.67% |
| 2017 | -160.66% | 12.39% |
| 2016 | -142.94% | -71.47% |
| 2015 | -500.99% | 399.78% |
| 2014 | -100.24% | 153.06% |
| 2013 | -39.61% | -123.55% |
| 2012 | 168.20% | -75.32% |
Heat Biologics, Inc. (HTBX) Average ROE
How has HTBX ROE performed in the past?
The current ROE of Heat Biologics, Inc. (HTBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-67.17%
5-year avg
-82.82%
10-year avg
-102.97%
Heat Biologics, Inc. (HTBX) ROE vs. Peers
How is HTBX’s ROE compared to its peers?
Heat Biologics, Inc.’s ROE is greater than Achilles Therapeutics plc (-41.05%), greater than Reneo Pharmaceuticals, Inc. (0%), greater than TCR2 Therapeutics Inc. (-71.90%), greater than Sigilon Therapeutics, Inc. (-74.73%), greater than Surface Oncology, Inc. (-61.52%), greater than Kronos Bio, Inc. (-40.83%), greater than Quince Therapeutics, Inc. (1.82%), greater than MindWalk Holdings Corp. (-63.24%), greater than AlloVir, Inc. (-72.78%), greater than The Valens Company Inc. (-25.35%),
| Company | ROE | Market cap |
|---|---|---|
| -41.05% | $60.83M | |
| 0% | $60.84M | |
| -71.90% | $58.11M | |
| -74.73% | $56.22M | |
| -61.52% | $65.08M | |
| -40.83% | $53.65M | |
| 1.82% | $5.20M | |
| -63.24% | $72.87M | |
| -72.78% | $49.48M | |
| -25.35% | $61.46M |
Build a custom stock screener for Heat Biologics, Inc. (HTBX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heat Biologics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Heat Biologics, Inc. (HTBX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Heat Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Heat Biologics, Inc.'s ROE?
How is the ROE calculated for Heat Biologics, Inc. (HTBX)?
What is the highest ROE for Heat Biologics, Inc. (HTBX)?
What is the 3-year average ROE for Heat Biologics, Inc. (HTBX)?
What is the 5-year average ROE for Heat Biologics, Inc. (HTBX)?
How does the current ROE for Heat Biologics, Inc. (HTBX) compare to its historical average?